Gene: AKR1C8
Official Full Name: aldo-keto reductase family 1 member C8provided by HGNC
Gene Summary: Predicted to enable aldo-keto reductase (NADPH) activity and estradiol 17-beta-dehydrogenase [NAD(P)+] activity. Predicted to be involved in prostaglandin biosynthetic process. Predicted to be located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19907 | AKR1C8 Knockout cell line (HeLa) | Human | AKR1C8 | 1:3~1:6 | Negative | Online Inquiry |
KO19908 | AKR1C8 Knockout cell line (HCT 116) | Human | AKR1C8 | 1:2~1:4 | Negative | Online Inquiry |
KO19909 | AKR1C8 Knockout cell line (HEK293) | Human | AKR1C8 | 1:3~1:6 | Negative | Online Inquiry |
KO19910 | AKR1C8 Knockout cell line (A549) | Human | AKR1C8 | 1:3~1:4 | Negative | Online Inquiry |
AKR1C8 Gene Knockout Cell Lines are specially engineered cellular models that have been genetically modified to disable the expression of the aldo-keto reductase 1C8 gene. This gene plays a crucial role in the metabolism of steroid hormones and xenobiotics, making these cell lines an essential tool for investigating the biological functions of AKR1C8 in various physiological and pathological contexts. By eliminating the AKR1C8 gene, researchers can explore the impact of its absence on cellular processes, pathway regulation, and overall metabolic activity.
The primary mechanism of action involves the disruption of the AKR1C8 protein production, leading to altered metabolic pathways and changes in substrate interactions. This allows for in-depth studies on steroid hormone metabolism and the biological effects of pharmacologic agents, providing insights into drug metabolism and potential drug interactions.
In scientific research, AKR1C8 Gene Knockout Cell Lines serve as foundational models in pharmacology, toxicology, and endocrinology. Their applications extend to drug development, where understanding the role of AKR1C8 can aid in optimizing therapeutic profiles and minimizing side effects related to steroid usage in clinical settings. Moreover, these cell lines facilitate the exploration of various disease mechanisms, including hormone-dependent cancers and metabolic disorders.
What sets our AKR1C8 Gene Knockout Cell Lines apart from alternatives is their high specificity and reliability in experimental outcomes. Designed using advanced CRISPR-Cas9 technology, these models exhibit consistent knockout efficiency and stability, thereby ensuring reproducibility in experiments. Researchers and clinicians will find that utilizing our cell lines enhances the accuracy of their findings, ultimately contributing to more reliable conclusions and advancements in biological understanding.
By choosing our AKR1C8 Gene Knockout Cell Lines, you gain access to a product backed by our company’s extensive research expertise and commitment to quality. We are dedicated to providing cutting-edge biological tools that empower scientific discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.